标题
NK Cell-Based Immune Checkpoint Inhibition
作者
关键词
-
出版物
Frontiers in Immunology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-02-13
DOI
10.3389/fimmu.2020.00167
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Monitoring TIGIT/DNAM-1 and PVR/PVRL2 immune checkpoint's expression levels in allogeneic stem cell transplantation for acute myeloid leukemia
- (2019) Norimichi Hattori et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies
- (2019) Zofia Pilch et al. PLoS One
- Interaction of CD200 Overexpression on Tumor Cells with CD200R1 Overexpression on Stromal Cells: An Escape from the Host Immune Response in Rectal Cancer Patients
- (2019) Atil Bisgin et al. Journal of Oncology
- The role of cytokines in the regulation of NK cells in the tumor environment
- (2019) Gordana M. Konjević et al. CYTOKINE
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More
- (2019) Massimo Vitale et al. Frontiers in Immunology
- IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial
- (2019) Martine Bagot et al. LANCET ONCOLOGY
- NK Cell Metabolism and Tumor Microenvironment
- (2019) Iñigo Terrén et al. Frontiers in Immunology
- The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer
- (2018) ANTICANCER RESEARCH
- TIGIT immune checkpoint blockade restores CD8+T cell immunity against multiple myeloma
- (2018) Camille Guillerey et al. BLOOD
- Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL
- (2018) Frank Vari et al. BLOOD
- Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma
- (2018) Furong Liu et al. BULLETIN DU CANCER
- Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
- (2018) Robert L. Ferris et al. CANCER TREATMENT REVIEWS
- Tumor immunotherapy: New aspects of natural killer cells
- (2018) Yangxi Li et al. Chinese Journal of Cancer Research
- A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
- (2018) Fevzi Firat Yalniz et al. Clinical Lymphoma Myeloma & Leukemia
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Immune Checkpoint Blockade across the Cancer Care Continuum
- (2018) Beth A. Helmink et al. IMMUNITY
- A Developed NK-92MI Cell Line with Siglec-7neg Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells
- (2018) Chin-Han Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
- (2018) Karen O. Dixon et al. JOURNAL OF IMMUNOLOGY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation
- (2018) Qian Xiao et al. NATURE MEDICINE
- Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression
- (2018) Pilar M. Lanuza et al. OncoImmunology
- TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
- (2018) Alice L. Hung et al. OncoImmunology
- Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
- (2018) Kristin C. Hicks et al. OncoImmunology
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Myeloma-escape after stem cell transplantation is a consequence of T cell exhaustion and is prevented by TIGIT blockade
- (2018) Simone A. Minnie et al. BLOOD
- TIGIT: a novel immunotherapy target moving from bench to bedside
- (2018) Benjamin L. Solomon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Abstract 4745: Tim-3 and TIGIT mark NK and T cells susceptible to effector dysfunction in human bladder cancer
- (2018) Adam M. Farkas et al. CANCER RESEARCH
- Abstract 2713: Preclinical development of first-in-class antibodies targeting Siglec-9 immune checkpoint for cancer immunotherapy
- (2018) Olivier Bénac et al. CANCER RESEARCH
- Abstract 2714: Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers
- (2018) Caroline Soulas et al. CANCER RESEARCH
- Abstract CT158: Phase II study of monalizumab, a first-in-class NKG2A monoclonal antibody, in combination with cetuximab in previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Preliminary assessment of safety and efficacy
- (2018) Roger Cohen et al. CANCER RESEARCH
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- First-in-human dose escalation of monalizumab plus durvalumab, with expansion in patients with metastatic microsatellite-stable colorectal cancer.
- (2018) Neil Howard Segal et al. JOURNAL OF CLINICAL ONCOLOGY
- Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
- (2018) Hauke Stamm et al. MAMMALIAN GENOME
- Correlation of T Cell Immunoglobulin and ITIM Domain (TIGIT) and Programmed Death 1 (PD-1) with Clinicopathological Characteristics of Renal Cell Carcinoma May Indicate Potential Targets for Treatment
- (2018) Xin Hong et al. MEDICAL SCIENCE MONITOR
- Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
- (2018) Estefanía Paula Juliá et al. Frontiers in Immunology
- Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
- (2018) Arum Park et al. Frontiers in Immunology
- Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
- (2018) Aifen Lin et al. Frontiers in Immunology
- Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
- (2018) Wenchao Li et al. BMC CANCER
- NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
- (2018) Nadine van Montfoort et al. CELL
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Targeting PVR (CD155) and its receptors in anti-tumor therapy
- (2018) Paola Kučan Brlić et al. Cellular & Molecular Immunology
- Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma
- (2018) Haoyu Sun et al. HEPATOLOGY
- Nobel goes to immune checkpoint—Innovative cancer treatment by immunotherapy
- (2018) Jing Li et al. Science China-Life Sciences
- Structural Basis for CD96 Immune Receptor Recognition of Nectin-like Protein-5, CD155
- (2018) Felix A. Deuss et al. STRUCTURE
- TIM-3, a promising target for cancer immunotherapy
- (2018) Yayi He et al. OncoTargets and Therapy
- PD-L1 Mediates Dysfunction in Activated PD-1+ NK Cells in Head and Neck Cancer Patients
- (2018) Fernando Concha-Benavente et al. Cancer Immunology Research
- CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
- (2018) Pulak Ranjan Nath et al. Frontiers in Immunology
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
- (2018) Xiu-Man Zhou et al. Frontiers in Immunology
- Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
- (2018) Mónica Villa-Álvarez et al. Frontiers in Immunology
- PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
- (2018) Francesca R. Mariotti et al. OncoImmunology
- Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer
- (2017) Olivia Joan Adams et al. GLYCOBIOLOGY
- The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3
- (2017) Murali Janakiram et al. IMMUNOLOGICAL REVIEWS
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy
- (2017) William C. Dougall et al. IMMUNOLOGICAL REVIEWS
- Leveraging natural killer cells for cancer immunotherapy
- (2017) Steven K Grossenbacher et al. Immunotherapy
- A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
- (2017) Irina Kareva INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
- (2017) Wenwen Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT)
- (2017) Felix A. Deuss et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
- (2017) Julia A. Wagner, Maximillian Rosario, Rizwan Romee, Melissa M. Berrien-Elliott, Stephanie E. Schneider, Jeffrey W. Leong, Ryan P. Sullivan, Brea A. Jewell, Michelle Becker-Hapak, Timothy Schappe, Sara Abdel-Latif, Aaron R. Ireland, Devika Jaishankar, Justin A. King, Ravi Vij, Dennis Clement, Jodie Goodridge, Karl-Johan Malmberg, Hing C. Wong, Todd A. Fehniger JOURNAL OF CLINICAL INVESTIGATION
- PD-1 regulates KLRG1+group 2 innate lymphoid cells
- (2017) Samuel Taylor et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New B7 Family Checkpoints in Human Cancers
- (2017) Ling Ni et al. MOLECULAR CANCER THERAPEUTICS
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients
- (2017) Richard Linedale et al. PLoS One
- Emerging targets in cancer immunotherapy
- (2017) Samantha Burugu et al. SEMINARS IN CANCER BIOLOGY
- Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
- (2017) Laura Chiossone et al. SEMINARS IN IMMUNOLOGY
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Poliovirus Receptor: More than a simple viral receptor
- (2017) Jonathan R. Bowers et al. VIRUS RESEARCH
- IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
- (2017) Hyungseok Seo et al. Nature Communications
- Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis
- (2017) Ewelina Krzywinska et al. Nature Communications
- Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
- (2017) Jonas R.M. Van Audenaerde et al. Oncotarget
- Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression
- (2017) Massimo Giuliani et al. Oncotarget
- IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients
- (2017) Rossana Tallerico et al. OncoImmunology
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Lymphocyte-activation gene-3, an important immune checkpoint in cancer
- (2016) Yayi He et al. CANCER SCIENCE
- Liver-infiltrating CD11b−CD27− NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression
- (2016) Qiong-Fang Zhang et al. Cellular & Molecular Immunology
- B7-H3 Overexpression Predicts Poor Survival of Cancer Patients: A Meta-Analysis
- (2016) Zhimeng Ye et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
- (2016) Y. Kong et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
- (2016) S. J. Blake et al. CLINICAL CANCER RESEARCH
- Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
- (2016) M. Carlsten et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
- (2016) E. Picarda et al. CLINICAL CANCER RESEARCH
- Targeting NKG2D and NKp30 Ligands Shedding to Improve NK Cell-Based Immunotherapy
- (2016) Alessandra Zingoni et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Dose ranging study of monalizumab (IPH2201) in patients with gynecologic malignancies: A trial of the Canadian Cancer Trials Group (CCTG): IND221
- (2016) A. Tinker et al. EUROPEAN JOURNAL OF CANCER
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- TIGIT, A Novel Therapeutic Target for Tumor Immunotherapy
- (2016) Xin-guang Liu et al. IMMUNOLOGICAL INVESTIGATIONS
- Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial
- (2016) Sergio Amadori et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
- (2016) Alexander M. Lesokhin et al. JOURNAL OF CLINICAL ONCOLOGY
- A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+Melanoma
- (2016) Jin-Qing Liu et al. JOURNAL OF IMMUNOLOGY
- Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines
- (2016) Jingwei Liu et al. JOURNAL OF IMMUNOTHERAPY
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision glycocalyx editing as a strategy for cancer immunotherapy
- (2016) Han Xiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Thrombospondin-1 signaling through CD47 inhibits cell cycle progression and induces senescence in endothelial cells
- (2016) Qi Gao et al. Cell Death & Disease
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- Altered expression of CD226 and CD96 on natural killer cells in patients with pancreatic cancer
- (2016) Yun-Peng Peng et al. Oncotarget
- PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma
- (2016) Asma Beldi-Ferchiou et al. Oncotarget
- Recognition and Regulation of T Cells by NK Cells
- (2016) Katharina Pallmer et al. Frontiers in Immunology
- Features of Memory-Like and PD-1+ Human NK Cell Subsets
- (2016) Mariella Della Chiesa et al. Frontiers in Immunology
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer
- (2016) Cheng Sun et al. OncoImmunology
- Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
- (2016) Emily M. McWilliams et al. OncoImmunology
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
- (2016) Casey Ager et al. Journal for ImmunoTherapy of Cancer
- Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway
- (2016) Jintang Sun et al. PLoS One
- IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo
- (2016) Joanna S. Kritikou et al. Scientific Reports
- Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
- (2015) Cheng Sun et al. ACTA PHARMACOLOGICA SINICA
- Short Communication: Low Expression of Activation and Inhibitory Molecules on NK Cells and CD4+ T Cells Is Associated with Viral Control
- (2015) Natalia A. Taborda et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- CTLA-4+Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
- (2015) Hyun-Bae Jie et al. CANCER RESEARCH
- Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer
- (2015) Hui Zheng et al. CANCER SCIENCE
- Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors
- (2015) Xunlei Kang et al. CELL CYCLE
- Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
- (2015) Dalil Hannani et al. CELL RESEARCH
- A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
- (2015) D. M. Benson et al. CLINICAL CANCER RESEARCH
- LC–MS/MS glycomic analyses of free and conjugated forms of the sialic acids, Neu5Ac, Neu5Gc and KDN in human throat cancers
- (2015) Fang Wang et al. GLYCOBIOLOGY
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer
- (2015) Zhenxin Wang et al. IMMUNOLOGICAL INVESTIGATIONS
- Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1
- (2015) Amer Assal et al. Immunotherapy
- Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
- (2015) Liyun Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunosurveillance and therapy of multiple myeloma are CD226 dependent
- (2015) Camille Guillerey et al. JOURNAL OF CLINICAL INVESTIGATION
- TIGIT and PD-1 impair tumor antigen–specific CD8+ T cells in melanoma patients
- (2015) Joe-Marc Chauvin et al. JOURNAL OF CLINICAL INVESTIGATION
- TIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells
- (2015) Valentina Folgiero et al. Journal of Hematology & Oncology
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors
- (2015) HIDEO KOMITA et al. ONCOLOGY REPORTS
- Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
- (2015) Emanuela Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment
- (2015) Jennifer A Juno et al. Retrovirology
- Inhibitory leukocyte immunoglobulin-like receptors in cancer development
- (2015) FeiFei Zhang et al. Science China-Life Sciences
- Confusing signals: Recent progress in CTLA-4 biology
- (2015) Lucy S.K. Walker et al. TRENDS IN IMMUNOLOGY
- Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells
- (2015) L. Ruggeri et al. HAEMATOLOGICA
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3
- (2015) John Powderly et al. Journal for ImmunoTherapy of Cancer
- NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade
- (2015) Frederick J Kohlhapp et al. Journal for ImmunoTherapy of Cancer
- The PD-1/B7-H1 Pathway Modulates the Natural Killer Cells versus Mouse Glioma Stem Cells
- (2015) Bo Yuan Huang et al. PLoS One
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway
- (2015) Brian Tomkowicz et al. PLoS One
- CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
- (2014) D. R. Soto-Pantoja et al. CANCER RESEARCH
- LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
- (2014) F. Xu et al. CANCER RESEARCH
- NK/DC crosstalk in immunosurveillance: A broken relationship caused by WASP-deficiency
- (2014) Chiara Romagnani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Effect of tumor cells and tumor microenvironment on NK-cell function
- (2014) Massimo Vitale et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
- (2014) N. Korde et al. HAEMATOLOGICA
- Human Natural Killer Cells: Origin, Receptors, Function, and Clinical Applications
- (2014) Lorenzo Moretta et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer
- (2014) Estrella Levy et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- T-cell Immunoglobulin and ITIM Domain (TIGIT) Receptor/Poliovirus Receptor (PVR) Ligand Engagement Suppresses Interferon-γ Production of Natural Killer Cells via β-Arrestin 2-mediated Negative Signaling
- (2014) Man Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets
- (2014) M. T. M. Vossen et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Programmed Death-1 Expression Is Increased on Immunocytes in Chronic Hepatitis C Virus and Predicts Failure of Response to Antiviral Therapy: Race-Dependent Differences
- (2014) L. Golden-Mason et al. JOURNAL OF IMMUNOLOGY
- Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy
- (2014) Liat Binyamin et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Programmed Death-1/Programmed Death Ligand 1 Interaction Regulates the Induction and Maintenance of Invariant NKT Cell Anergy
- (2014) W.-S. Chang et al. JOURNAL OF IMMUNOLOGY
- CD47 Signaling Regulates the Immunosuppressive Activity of VEGF in T Cells
- (2014) Sukhbir Kaur et al. JOURNAL OF IMMUNOLOGY
- CTLA-4 Is Expressed by Activated Mouse NK Cells and Inhibits NK Cell IFN- Production in Response to Mature Dendritic Cells
- (2014) A. Stojanovic et al. JOURNAL OF IMMUNOLOGY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
- (2014) Hongyan Hou et al. PLoS One
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- The Dual Role of HLA-G in Cancer
- (2014) Nathalie Rouas-Freiss et al. Journal of Immunology Research
- Reversal of natural killer cell exhaustion by TIM-3 blockade
- (2014) Anne Gallois et al. OncoImmunology
- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Wiskott-Aldrich syndrome protein deficiency in natural killer and dendritic cells affects antitumor immunity
- (2013) Marco Catucci et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Subsets of human natural killer cells and their regulatory effects
- (2013) Binqing Fu et al. IMMUNOLOGY
- HIV Infection Deregulates Tim-3 Expression on Innate Cells
- (2013) Constance A.M. Finney et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T cell regulation of natural killer cells
- (2013) Yann Kerdiles et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production
- (2013) Stefania Laurent et al. Journal of Translational Medicine
- Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
- (2013) L. Golden-Mason et al. JOURNAL OF VIROLOGY
- A Novel Cancer Therapeutic Using Thrombospondin 1 in Dendritic Cells
- (2013) Tzu-Yang Weng et al. MOLECULAR THERAPY
- Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
- (2013) Jason E Hudak et al. Nature Chemical Biology
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
- (2013) Stephanie Jost et al. Retrovirology
- Thrombospondin-1 Signaling through CD47 Inhibits Self-renewal by Regulating c-Myc and Other Stem Cell Transcription Factors
- (2013) Sukhbir Kaur et al. Scientific Reports
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection
- (2013) A. W. MacFarlane et al. Cancer Immunology Research
- Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells
- (2013) Gencheng Han et al. Frontiers in Immunology
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
- (2012) N. Vey et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
- (2012) D. M. Benson et al. BLOOD
- Cancer-Induced Immunosuppression: IL-18-Elicited Immunoablative NK Cells
- (2012) M. Terme et al. CANCER RESEARCH
- Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells
- (2012) S Liu et al. CELL DEATH AND DIFFERENTIATION
- Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma
- (2012) Silke Heidenreich et al. Clinical & Developmental Immunology
- Development of an Fc-Enhanced Anti-B7-H3 Monoclonal Antibody with Potent Antitumor Activity
- (2012) D. Loo et al. CLINICAL CANCER RESEARCH
- NK cell MHC class I specific receptors (KIR): from biology to clinical intervention
- (2012) Ariane Thielens et al. CURRENT OPINION IN IMMUNOLOGY
- CD200R signaling in tumor tolerance and inflammation: A tricky balance
- (2012) Tomasz P Rygiel et al. CURRENT OPINION IN IMMUNOLOGY
- Blockade of Tim-3 signaling restores the virus-specific CD8+T-cell response in patients with chronic hepatitis B
- (2012) Wei Wu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells
- (2012) Fabian Wolpert et al. JOURNAL OF NEUROIMMUNOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction
- (2012) A Naji et al. LEUKEMIA
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Characterisation of Bovine Leukocyte Ig-like Receptors
- (2012) Louise Hogan et al. PLoS One
- Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
- (2012) Gaia Nebbia et al. PLoS One
- PD-1 Expression on Natural Killer Cells and CD8+ T Cells During Chronic HIV-1 Infection
- (2012) Sonia Norris et al. VIRAL IMMUNOLOGY
- Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells
- (2011) F. Morandi et al. BLOOD
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
- (2011) D. M. Benson et al. BLOOD
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- Ipilimumab
- (2011) Fiona Cameron et al. DRUGS
- Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD
- (2011) Silke Wiesmayr et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
- (2011) Valerie Chew et al. GUT
- Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family
- (2011) Hélène Bour-Jordan et al. IMMUNOLOGICAL REVIEWS
- Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
- (2011) Kerry S. Campbell et al. IMMUNOLOGY
- HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression
- (2011) Céline Bossard et al. INTERNATIONAL JOURNAL OF CANCER
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
- (2011) S J Coles et al. LEUKEMIA
- Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
- (2011) J. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor
- (2011) T P Rygiel et al. ONCOGENE
- Multifunctional immune-modulatory protein HLA-E identified in classical Hodgkin lymphoma: Possible implications
- (2011) Leos Kren et al. PATHOLOGY RESEARCH AND PRACTICE
- HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
- (2011) M. Gooden et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor–Negative Natural Killer Cells after NKG2A and LIR-1 Blockade
- (2010) Robert Godal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- Natural killer cells and cancer: Regulation by the killer cell Ig-like receptors (KIR)
- (2010) Amanda K. Purdy et al. CANCER BIOLOGY & THERAPY
- The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- (2010) Magda Stumpfova et al. CANCER RESEARCH
- The CD4-like molecule LAG-3, biology and therapeutic applications
- (2010) Sophie Sierro et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
- (2010) Ying Ju et al. JOURNAL OF HEPATOLOGY
- LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
- (2010) C. Camisaschi et al. JOURNAL OF IMMUNOLOGY
- Role Played by the Programmed Death‐1–Programmed Death Ligand Pathway during Innate Immunity againstMycobacterium tuberculosis
- (2010) Ivana B. Alvarez et al. JOURNAL OF INFECTIOUS DISEASES
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
- (2010) Chrystelle Brignone et al. Journal of Translational Medicine
- Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: An unexpected prognostic significance?
- (2010) Leos Kren et al. NEUROPATHOLOGY
- Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
- (2010) H.-T. Jin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
- (2009) Reginald M. Gorczynski et al. BREAST CANCER RESEARCH AND TREATMENT
- CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells
- (2009) Lorenzo Brunetti et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
- (2009) C. Brignone et al. CLINICAL CANCER RESEARCH
- ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse
- (2009) Benoit Favier et al. FASEB JOURNAL
- Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
- (2009) Estrella Mariel Levy et al. Innate Immunity
- Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer
- (2009) A. Lin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma
- (2009) A. Lin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
- (2009) C. J. Workman et al. JOURNAL OF IMMUNOLOGY
- Essential Roles for Dok2 and RasGAP in CD200 Receptor-Mediated Regulation of Human Myeloid Cells
- (2009) R. Mihrshahi et al. JOURNAL OF IMMUNOLOGY
- Regression of pancreatic cancer from ipilimumab (anti-CTLA-4) mediated by an NK-cell subset (CD56brightCD16dim)
- (2009) Timothy L. Frankel et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
- (2009) N. Stanietsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
- Negative signaling by inhibitory receptors: the NK cell paradigm
- (2008) Eric O. Long IMMUNOLOGICAL REVIEWS
- Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future
- (2008) Marc Daëron et al. IMMUNOLOGICAL REVIEWS
- Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells
- (2008) Richard K. Tsai et al. JOURNAL OF CELL BIOLOGY
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
- (2008) Shawn D Blackburn et al. NATURE IMMUNOLOGY
- The contrasting role of B7-H3
- (2008) K. A. Hofmeyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The genetic and evolutionary balances in human NK cell receptor diversity
- (2008) Peter Parham SEMINARS IN IMMUNOLOGY
- HLA-G: from biology to clinical benefits
- (2008) Edgardo D. Carosella et al. TRENDS IN IMMUNOLOGY
- Association of CD47 with Natural Killer Cell-Mediated Cytotoxicity of Head-and-Neck Squamous Cell Carcinoma Lines
- (2008) Min Jung Kim et al. TUMOR BIOLOGY
- CD200: A putative therapeutic target in cancer
- (2007) Jérôme Moreaux et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes
- (2007) Eva S.K. Rijkers et al. MOLECULAR IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now